US 11850226
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted A61KA61K31/27A61K31/325
Quick answer
US patent 11850226 (Methods of providing solriamfetol therapy to subjects with impaired renal function) held by AXSOME MALTA LTD. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME MALTA LTD.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/27, A61K31/325, A61K9/0053, A61P